The earnings results for Bioventus (NASDAQ:BVS) for Q4 were made public on Thursday, March 5, 2026 at 07:30 AM.

Here's a comprehensive overview of the announcement.

Earnings

Bioventus beat estimated earnings by 9.09%, reporting an EPS of $0.24 versus an estimate of $0.22.

Revenue was up $4.26 million from the same period last year.

Analysis of Past Earnings

The company beat on EPS by $0.03 in the previous quarter, leading to a 2.25% drop share price change the next day.

Here's a look at Bioventus's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.12	0.21	0.02	0.08
EPS Actual	0.15	0.21	0.08	0.15
Revenue Estimate	138.19M	146.74M	122.71M	145.16M
Revenue Actual	138.65M	147.66M	123.88M	153.64M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Bioventus management provided guidance for FY 2026, expecting earnings between $0.73 and $0.77 per share.

To track all earnings releases for Bioventus visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.